Fr. Andrea Vicini

Q: What Schools Are Affiliated With Fr. Andrea Vicini

Fr. Andrea Vicini is affiliated with the following schools: University of Michigan, Vanderbilt University, Virginia Commonwealth University

Fr. Andrea Vicini's AcademicInfluence.com Rankings

Fr. Andrea Vicini

Medical

#2115

World Rank

#2515

Historical Rank

Oncology

#116

World Rank

#120

Historical Rank

medical Degrees

Download Badge

Medical

Fr. Andrea Vicini's Degrees

Masters Medicine Harvard University

Why Is Fr. Andrea Vicini Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Fr. Andrea Vicini's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). (2009) (615)
Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. (1994) (559)
Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. (1992) (456)
Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. (1991) (420)
Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. (2003) (399)
Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy. (2001) (376)
Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. (2003) (375)
Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). (2005) (353)
Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. (2002) (342)
Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study. (2007) (329)
Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. (2000) (329)
Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). (2009) (315)
Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. (2003) (302)
Adaptive radiation therapy. (1997) (302)
Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. (2011) (300)
Limited-field radiation therapy in the management of early-stage breast cancer. (2003) (282)
Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). (2002) (282)
Image-detected breast cancer: state of the art diagnosis and treatment. (2005) (277)
Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. (1991) (276)
Adaptive modification of treatment planning to minimize the deleterious effects of treatment setup errors. (1997) (243)
Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. (2003) (235)
Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. (2005) (235)
Initial clinical experience with moderate deep-inspiration breath hold using an active breathing control device in the treatment of patients with left-sided breast cancer using external beam radiation therapy. (2003) (234)
Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial (2019) (230)
Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. (2007) (228)
Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer. (2002) (225)
Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. (2002) (211)
Accelerated partial breast irradiation as a part of breast conservation therapy. (2005) (208)
Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer. (2001) (200)
Long‐term outcome after breast‐conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast (2005) (196)
Accelerated treatment of breast cancer. (2001) (191)
The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. (2001) (184)
Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome. (1991) (181)
Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. (2007) (174)
Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy. (2000) (170)
Three‐year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI) (2008) (160)
Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. (2001) (159)
Are cosmetic results following conservative surgery and radiation therapy for early breast cancer dependent on technique? (1992) (159)
Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. (2011) (158)
Long‐term cosmetic results and toxicity after accelerated partial‐breast irradiation (2006) (153)
Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy. (2011) (153)
First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity (2005) (149)
Computed tomography guided management of interfractional patient variation. (2005) (148)
The use of adaptive radiation therapy to reduce setup error: a prospective clinical study. (1998) (147)
Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/ II breast carcinoma. (2008) (146)
Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies. (2011) (144)
The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. (1991) (141)
The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation. (2013) (141)
Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer. (2012) (140)
The validity of surgical clips as a radiographic surrogate for the lumpectomy cavity in image-guided accelerated partial breast irradiation. (2004) (139)
A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319. (2005) (139)
Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume? (2002) (137)
Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience. (2007) (137)
Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. (2010) (137)
Cardiac dose sparing and avoidance techniques in breast cancer radiotherapy. (2014) (136)
Special report: Consensus conference III. Image-detected breast cancer: state-of-the-art diagnosis and treatment. (2009) (136)
The American Brachytherapy Society consensus statement for accelerated partial breast irradiation. (2013) (136)
Does local recurrence affect the rate of distant metastases and survival in patients with early‐stage breast carcinoma treated with breast‐conserving therapy? (2003) (135)
Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up. (2009) (134)
Six-year Experience Routinely Using Moderate Deep Inspiration Breath-hold for the Reduction of Cardiac Dose in Left-sided Breast Irradiation for Patients With Early-stage or Locally Advanced Breast Cancer (2013) (134)
Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis. (2004) (134)
Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. (2003) (133)
Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: results of a matched-pair analysis. (2011) (132)
The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer. (1999) (132)
A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer. (2005) (127)
Treatment Efficacy with Accelerated Partial Breast Irradiation (APBI): Final Analysis of the American Society of Breast Surgeons MammoSite® Breast Brachytherapy Registry Trial (2013) (126)
Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early-stage breast cancer: 2-year results. (2008) (126)
Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer. (1991) (124)
Irradiation of the tumor bed alone after lumpectomy in selected patients with early‐stage breast cancer treated with breast conserving therapy (1999) (119)
Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer. (2000) (116)
Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference (2015) (116)
Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. (2007) (115)
Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors. (2003) (115)
Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial. (2000) (113)
Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer. (1999) (113)
Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature. (2002) (113)
Impact of breathing motion on whole breast radiotherapy: a dosimetric analysis using active breathing control. (2004) (112)
The impact of early detection and intervention of breast cancer‐related lymphedema: a systematic review (2016) (112)
Accelerated partial breast irradiation: a dosimetric comparison of three different techniques. (2005) (109)
Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes. (2002) (108)
Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy. (2002) (108)
Improving Symptoms and Quality of Life of Female Cancer Survivors: a Randomized Controlled Study (2012) (108)
Acute and Subacute Toxicity Associated with Concurrent Adjuvant Radiation Therapy and Paclitaxel in Primary Breast Cancer Therapy (2002) (105)
Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. (2005) (105)
Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy (2007) (101)
Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial. (1995) (101)
OT2-06-02: A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) vs Partial Breast Irradiation (PBI) for Women with Stage 0, 1, or 2 Breast Cancer: NSABP B-39/RTOG 0413. (2011) (100)
Accelerated Partial Breast Irradiation After Conservative Surgery for Breast Cancer (2004) (100)
Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I/II clinical trial. (1995) (100)
Low-dose-rate brachytherapy as the sole radiation modality in the management of patients with early-stage breast cancer treated with breast-conserving therapy: preliminary results of a pilot trial. (1997) (99)
Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low/intermediate prostate cancer. (2012) (99)
Three-dimensional evaluation of intra- and interfraction immobilization of lung and chest wall using active breathing control: a reproducibility study with breast cancer patients. (2003) (99)
Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study. (2007) (96)
Workshop on partial breast irradiation: state of the art and the science, Bethesda, MD, December 8-10, 2002. (2004) (96)
Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy (1999) (96)
Surgical considerations in the treatment of early stage breast cancer with accelerated partial breast irradiation (APBI) in breast conserving therapy via intersitial brachytherapy (2004) (92)
Early toxicity results with 3D conformal external beam therapy (CEBT) from the NSABP B-39/RTOG 0413 accelerated partial breast irradiation (APBI) trial. (2011) (91)
Clinicopathologic analysis of extracapsular extension in prostate cancer: should the clinical target volume be expanded posterolaterally to account for microscopic extension? (2004) (91)
Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel (2017) (86)
Breast brachytherapy: North American experience. (2005) (86)
Long-term efficacy and patterns of failure after accelerated partial breast irradiation: a molecular assay-based clonality evaluation. (2007) (86)
Practical application of biochemical failure definitions: what to do and when to do it. (2001) (83)
Accelerated partial breast irradiation (2011) (82)
Treatment outcome with radiation therapy after breast augmentation or reconstruction in patients with primary breast carcinoma (1998) (81)
Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer. (1999) (81)
Five‐year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation (2010) (79)
Defining the efficacy of accelerated partial breast irradiation: the importance of proper patient selection, optimal quality assurance, and common sense. (2003) (76)
The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy. (1997) (75)
Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies. (1999) (75)
Implementation of 3D-virtual brachytherapy in the management of breast cancer: a description of a new method of interstitial brachytherapy. (1998) (74)
Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinoma treated with breast-conserving therapy. A clinicopathologic study of 607 neoplasms from 583 patients. (2003) (74)
A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution (2000) (73)
Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma‐in‐situ treated with breast‐conserving therapy (2001) (73)
Lack of benefit for the addition of androgen deprivation therapy to dose-escalated radiotherapy in the treatment of intermediate- and high-risk prostate cancer. (2008) (72)
Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer. (2011) (72)
Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. (2005) (71)
Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care. (2011) (71)
Limitations of the American Society of Therapeutic Radiology and Oncology Consensus Panel guidelines on the use of accelerated partial breast irradiation. (2010) (69)
Changes in temporal patterns of local failure after breast-conserving therapy and their prognostic implications. (2004) (69)
The conservative management of Paget's disease of the breast with radiotherapy (1997) (68)
An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow‐up (2002) (68)
Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial. (2009) (67)
Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features. (2002) (67)
A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity. (2005) (65)
Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema, Recommendations from an Expert Panel: Part 2: Preventive and Therapeutic Options (2017) (65)
MRI-based volumetric assessment of cardiac anatomy and dose reduction via active breathing control during irradiation for left-sided breast cancer. (2005) (63)
A comprehensive review of prostate cancer brachytherapy: defining an optimal technique. (1999) (63)
Failure rate and cosmesis of immediate tissue expander/implant breast reconstruction after postmastectomy irradiation. (2012) (63)
Recurrence in the breast following conservative surgery and radiation therapy for early-stage breast cancer. (1992) (63)
Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast‐conserving therapy (2000) (62)
Initial Outcomes for Patients Treated on the American Society of Breast Surgeons MammoSite Clinical Trial for Ductal Carcinoma-In-Situ of the Breast (2006) (62)
Salvage treatment for local recurrence after breast‐conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast (2001) (61)
Intraoperative Radiation Therapy: A Critical Analysis of the ELIOT and TARGIT Trials. Part 2—TARGIT (2014) (61)
Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. (2006) (60)
Mammographic, pathologic, and treatment-related factors associated with local recurrence in patients with early-stage breast cancer treated with breast conserving therapy. (1999) (59)
Outcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma in situ of the breast treated with conservative surgery and radiation therapy. (1995) (58)
Six-Year Analysis of Treatment-Related Toxicities in Patients Treated with Accelerated Partial Breast Irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial (2012) (58)
Breast‐Cancer Related Lymphedema: A Review of Procedure‐Specific Incidence Rates, Clinical Assessment Aids, Treatment Paradigms, and Risk Reduction (2012) (57)
RTOG 95-17, a Phase II trial to evaluate brachytherapy as the sole method of radiation therapy for Stage I and II breast carcinoma--year-5 toxicity and cosmesis. (2014) (57)
Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast: The role of preoperative mammograms in guiding treatment (1994) (56)
Impact of a Prostate Multidisciplinary Clinic Program on Patient Treatment Decisions and on Adherence to NCCN Guidelines: The William Beaumont Hospital Experience (2013) (56)
The emerging role of brachytherapy in the management of patients with breast cancer. (2002) (56)
Update on DCIS Outcomes from the American Society of Breast Surgeons Accelerated Partial Breast Irradiation Registry Trial (2010) (55)
Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age (2000) (55)
Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast‐conserving therapy at a single institution (2004) (55)
Excellent functional outcome in patients with squamous cell carcinoma of the base of tongue treated with external irradiation and interstitial iodine 125 boost (1996) (54)
Prognostic value of nodal ratios in node-positive breast cancer: a compiled update. (2009) (54)
Image guidance in external beam accelerated partial breast irradiation: comparison of surrogates for the lumpectomy cavity. (2005) (53)
Percentage of positive biopsy cores: a better risk stratification model for prostate cancer? (2012) (53)
Defining a dose-response relationship with radiotherapy for prostate cancer: is more really better? (2001) (53)
Improving the dosimetric coverage of interstitial high-dose-rate breast implants. (2000) (52)
Evaluating radiotherapy options in breast cancer: does intraoperative radiotherapy represent the most cost-efficacious option? (2014) (52)
Long term results with breast‐conserving therapy for patients with early stage breast carcinoma in a community hospital setting (1998) (51)
Limitations in the use of serum prostate specific antigen levels to monitor patients after treatment for prostate cancer. (2005) (51)
Bioimpedance Spectroscopy for Breast Cancer Related Lymphedema Assessment: Clinical Practice Guidelines (2016) (50)
Clinicopathologic implications of E‐cadherin reactivity in patients with lobular carcinoma in situ of the breast (2001) (50)
Long-term outcome with interstitial brachytherapy in the management of patients with early-stage breast cancer treated with breast-conserving therapy. (1997) (50)
Cost-efficacy of acceleration partial-breast irradiation compared with whole-breast irradiation (2013) (50)
Evaluation of current consensus statement recommendations for accelerated partial breast irradiation: a pooled analysis of William Beaumont Hospital and American Society of Breast Surgeon MammoSite Registry Trial Data. (2013) (49)
High dose rate endobronchial brachytherapy in the management of primary and recurrent bronchogenic malignancies (1995) (49)
Concurrent treatment planning for outpatient high dose rate prostate template implants. (1993) (48)
Treatment options for localized prostate cancer based on pretreatment serum prostate specific antigen levels. (1997) (47)
Percentage of positive biopsy cores as predictor of clinical outcome in prostate cancer treated with radiotherapy. (2001) (47)
Conservative management of Paget disease of the breast with radiotherapy (2003) (47)
Intraductal carcinoma of the breast: pathologic features associated with local recurrence in patients treated with breast-conserving therapy. (2000) (47)
The American Brachytherapy Society consensus statement on intraoperative radiation therapy. (2019) (46)
Bioelectrical impedance for detecting and monitoring patients for the development of upper limb lymphedema in the clinic. (2012) (45)
Molecular clonality determination of ipsilateral recurrence of invasive breast carcinomas after breast-conserving therapy: comparison with clinical and biologic factors. (2005) (45)
Late toxicity and patient self-assessment of breast appearance/satisfaction on RTOG 0319: a phase 2 trial of 3-dimensional conformal radiation therapy-accelerated partial breast irradiation following lumpectomy for stages I and II breast cancer. (2013) (45)
Long-term results from the Contura multilumen balloon breast brachytherapy catheter phase 4 registry trial. (2014) (45)
Conservative management of Paget disease of the breast with radiotherapy: 10- and 15-year results. (2002) (44)
Factors associated with the development of breast cancer-related lymphedema after whole-breast irradiation. (2012) (44)
Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment. (1997) (44)
Overview of accelerated partial breast irradiation (2008) (44)
Improvements in critical dosimetric endpoints using the Contura multilumen balloon breast brachytherapy catheter to deliver accelerated partial breast irradiation: preliminary dosimetric findings of a phase iv trial. (2011) (44)
Impact of Boost Technique on Outcome in Early-Stage Breast Cancer Patients Treated With Breast-Conserving Therapy (2001) (43)
Five-year outcomes and toxicities using 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. (2013) (43)
Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Brachytherapy Applicators Is Feasible and Safe: First Results From the TRIUMPH-T Trial. (2019) (43)
Accelerated treatment of breast cancer (2000) (43)
Ductal carcinoma in situ detected in the mammographic era: an analysis of clinical, pathologic, and treatment-related factors affecting outcome with breast-conserving therapy. (1997) (43)
Abstract GS4-04: Primary results of NSABP B-39/RTOG 0413 (NRG Oncology): A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer (2019) (42)
A Prospective Study of L-Dex Values in Breast Cancer Patients Pretreatment and Through 12 Months Postoperatively. (2018) (42)
Long-Term Cancer Outcomes From Study NRG Oncology/RTOG 9517: A Phase 2 Study of Accelerated Partial Breast Irradiation With Multicatheter Brachytherapy After Lumpectomy for Early-Stage Breast Cancer. (2016) (41)
Radiation Therapy Following Postmastectomy Reconstruction: A Systematic Review (2013) (41)
The use of ultrasonography in the localization of the lumpectomy cavity for interstitial brachytherapy of the breast. (1997) (41)
Should Ductal Carcinoma-in-situ (DCIS) Be Removed from the ASTRO Consensus Panel Cautionary Group for Off-protocol Use of Accelerated Partial Breast Irradiation (APBI)? A Pooled Analysis of Outcomes for 300 Patients with DCIS Treated with APBI (2013) (41)
Accelerated fractionation with a concurrent boost for early stage breast cancer. (2013) (40)
Brachytherapy-based partial breast irradiation is associated with low rates of complications and excellent cosmesis. (2013) (40)
Pathologic and mammographic findings predicting the adequacy of tumor excision before breast-conserving therapy. (1996) (40)
The role of high-dose rate brachytherapy in locally advanced prostate cancer. (2003) (40)
Continuous arc rotation of the couch therapy for the delivery of accelerated partial breast irradiation: a treatment planning analysis. (2011) (39)
The correlation of serial prostate specific antigen measurements with clinical outcome after external beam radiation therapy of patients for prostate carcinoma (2000) (39)
Factors Associated with Optimal Cosmetic Results at 36 Months in Patients Treated with Accelerated Partial Breast Irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite® Breast Brachytherapy Registry Trial (2009) (39)
High dose rate brachytherapy in the treatment of prostate cancer (2003) (39)
Effects of treatment setup variation on beam's eye view dosimetry for radiation therapy using the multileaf collimator vs. the cerrobend block. (1995) (38)
Practice guideline for the breast conservation therapy in the management of invasive breast carcinoma. (2007) (38)
Role of Internal Mammary Node Radiation as a Part of Modern Breast Cancer Radiation Therapy: A Systematic Review. (2016) (38)
Use of pathologic factors to assist in establishing adequacy of excision before radiotherapy in patients treated with breast-conserving therapy. (2004) (37)
Two-year outcome with the mammosite breast brachytherapy applicator: factors associated with optimal cosmetic results when performing partial breast irradiation (2003) (37)
Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema (2017) (37)
A Review of Treatment for Breast Cancer-Related Lymphedema: Paradigms for Clinical Practice (2016) (37)
A Cost Comparison Analysis of Adjuvant Radiation Therapy Techniques after Breast‐Conserving Surgery (2013) (37)
Dosimetric evaluation of the conformation of the multileaf collimator to irregularly shaped fields. (1995) (36)
Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants. (1999) (36)
Brachytherapy in the treatment of breast cancer. (2001) (36)
The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in‐breast failure in patients with early‐stage breast cancer treated with breast‐conserving therapy (2007) (36)
Langerhans cell histiocytosis involving the sphenoid sinus and superior orbital fissure. (1995) (35)
Potential for reduced toxicity and dose escalation in non-operable non-small cell lung cancer: a comparison of intensity-modulation, 3D-conformal radiation, and elective nodal irradiation (2003) (34)
Accelerated partial breast irradiation for pure ductal carcinoma in situ. (2010) (33)
Timing of Chemotherapy after MammoSite radiation therapy system breast brachytherapy: analysis of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. (2008) (33)
Four-year results using balloon-based brachytherapy to deliver accelerated partial breast irradiation with a 2-day dose fractionation schedule. (2012) (33)
Altered fractionation: rationale and justification for whole and partial breast hypofractionated radiotherapy. (2011) (33)
Hypofractionated regional nodal irradiation for breast cancer: examining the data and potential for future studies. (2014) (33)
Management of Ductal Carcinoma In Situ of the Breast: A Review. (2016) (32)
Intraoperative Radiation Therapy: A Critical Analysis of the ELIOT and TARGIT Trials. Part 1—ELIOT (2014) (32)
Phase I/II study evaluating early tolerance in breast cancer patients undergoing accelerated partial breast irradiation treated with the mammosite balloon breast brachytherapy catheter using a 2-day dose schedule. (2010) (31)
Long-term outcome in patients with ductal carcinoma in situ treated with breast-conserving therapy: implications for optimal follow-up strategies. (2012) (31)
Twenty-Year Outcomes after Breast-Conserving Surgery and Definitive Radiotherapy for Mammographically Detected Ductal Carcinoma In Situ (2012) (31)
Local control, toxicity, and cosmesis in women >70 years enrolled in the American Society of Breast Surgeons accelerated partial breast irradiation registry trial. (2012) (30)
Recurrent cancer after breast-conserving surgery with radiation therapy for ductal carcinoma in situ: mammographic features, method of detection, and stage of recurrence. (2007) (30)
Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ. (2005) (30)
Ductal carcinoma in situ treated with breast‐conserving surgery and accelerated partial breast irradiation (2011) (29)
The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy. (2006) (29)
Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. (2002) (29)
Prognostic significance of neuroendocrine differentiation in patients with Gleason score 8-10 prostate cancer treated with primary radiotherapy. (2011) (29)
Predictors of local recurrence following accelerated partial breast irradiation: a pooled analysis. (2012) (29)
Six-Year Results From a Phase I/II Trial for Hypofractionated Accelerated Partial Breast Irradiation Using a 2-Day Dose Schedule (2017) (28)
Radiation Therapy without Endocrine Therapy for Women Age 70 or Above with Low-Risk Early Breast Cancer: A Microsimulation. (2019) (28)
Cancerization of lobules and atypical ductal hyperplasia adjacent to ductal carcinoma in situ of the breast. (1998) (28)
Comparison of planned versus actual dose delivered for external beam accelerated partial breast irradiation using cone-beam CT and deformable registration. (2007) (28)
American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial: ductal carcinoma-in-situ subset analysis--4-year data in 194 treated lesions. (2009) (27)
Ductal Carcinoma in Situ of the Breast Treated with Accelerated Partial Breast Irradiation Using Balloon-Based Brachytherapy (2010) (27)
Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy. (2002) (27)
Dosimetric Feasibility and Acute Toxicity in a Prospective Trial of Ultrashort-Course Accelerated Partial Breast Irradiation (APBI) Using a Multi-Lumen Balloon Brachytherapy Device (2013) (27)
MammoSite radiation therapy system. (2003) (27)
Tumor Bed Control with Balloon-Based Accelerated Partial Breast Irradiation: Incidence of True Recurrences Versus Elsewhere Failures in the American Society of Breast Surgery MammoSite® Registry Trial (2012) (26)
Predictors of long-term toxicity using three-dimensional conformal external beam radiotherapy to deliver accelerated partial breast irradiation. (2011) (26)
Local Control, Toxicity, and Cosmesis in Women Younger Than 50 Enrolled Onto the American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial (2009) (26)
Long-Term Update of NRG Oncology RTOG 0319: A Phase 1 and 2 Trial to Evaluate 3-Dimensional Conformal Radiation Therapy Confined to the Region of the Lumpectomy Cavity for Stage I and II Breast Carcinoma. (2016) (26)
Clinical outcomes using accelerated partial breast irradiation in patients with ductal carcinoma in situ. (2012) (26)
Thirty-Nine Month Results with the MammoSite Brachytherapy Applicator: Details Regarding Cosmesis, Toxicity and Local Control in Partial Breast Irradiation (2005) (26)
Comparison of survival and regional failure between accelerated partial breast irradiation and whole breast irradiation. (2012) (25)
Response to "Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation" (Int J Radiat Oncol Biol Phys 2010;76:71-78) and "Toxicity of three-dimensional conformal radiotherapy for accelerated partial bre (2010) (25)
A planning comparison of 7 irradiation options allowed in RTOG 1005 for early-stage breast cancer. (2015) (25)
The use of bioimpedance spectroscopy to monitor therapeutic intervention in patients treated for breast cancer related lymphedema. (2013) (25)
Preventing Breast Cancer-Related Lymphedema in High-Risk Patients: The Impact of a Structured Surveillance Protocol Using Bioimpedance Spectroscopy (2018) (24)
The role of androgen deprivation in the definitive management of clinically localized prostate cancer treated with radiation therapy. (1999) (24)
Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalation. (2000) (24)
Contura Multi-Lumen Balloon breast brachytherapy catheter: comparative dosimetric findings of a phase 4 trial. (2013) (24)
Outcomes of breast cancer patients with triple negative receptor status treated with accelerated partial breast irradiation. (2010) (24)
PSA bounce after prostate brachytherapy with or without neoadjuvant androgen deprivation. (2010) (24)
Breast cancer: new radiation treatment options. (2004) (24)
The use of iodine-125 seeds as a substitute for iridium-192 seeds in temporary interstitial breast implants. (1993) (23)
Pathologic features of initial biopsy specimens associated with residual intraductal carcinoma on reexcision in patients with ductal carcinoma in situ of the breast referred for breast-conserving therapy. (1999) (23)
Cosmetic Outcome from Post Lumpectomy Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) on the NRG Oncology/NSABP B39-RTOG 0413 Phase III Clinical Trial (2019) (23)
Long‐Term Impact of Young Age at Diagnosis on Treatment Outcome and Patterns of Failure in Patients with Ductal Carcinoma In Situ Treated with Breast‐Conserving Therapy (2013) (23)
The histology of radiation therapy effect on prostate adenocarcinoma as assessed by needle biopsy after brachytherapy boost. Correlation with biochemical failure. (1998) (22)
Initial clinical experience with multilumen brachytherapy catheters for accelerated partial breast irradiation. (2012) (22)
Practical Implications of the Publication of Consensus Guidelines by the American Society for Radiation Oncology: Accelerated Partial Breast Irradiation and the National Cancer Data Base. (2016) (22)
Clinical evaluation of the mammosite breast brachytherapy catheter: an analysis of technical reproducibility, acute toxicity, and patient demographics (2003) (22)
Radiotherapy options for localized prostate cancer based upon pretreatment serum prostate-specific antigen levels and biochemical control: a comprehensive review of the literature. (1998) (22)
Long-Term Patterns of In-Breast Failure in Patients With Early Stage Breast Cancer Treated With Breast-Conserving Therapy: A Molecular Based Clonality Evaluation (2010) (22)
Molecular clonality relationships in initial carcinomas, ipsilateral breast failures, and distant metastases in patients treated with breast-conserving therapy: evidence suggesting that some distant metastases are derived from ipsilateral breast failures and that metastases can metastasize. (2005) (22)
Assessing the benefit of radiation therapy after breast-conserving surgery for ductal carcinoma-in-situ. (2005) (21)
Nation-Scale Adoption of Shorter Breast Radiation Therapy Schedules Can Increase Survival in Resource Constrained Economies: Results From a Markov Chain Analysis. (2017) (21)
Increasing accrual in cancer clinical trials with a focus on minority enrollment (2011) (21)
Is boost therapy necessary in the treatment of DCIS (2008) (21)
Differences in disease presentation, management techniques, treatment outcome, and toxicities in African‐American women with early stage breast cancer treated with breast‐conserving therapy (2010) (20)
Prognostic features in patients with stage T1 breast carcinoma and a 0.5-cm or less lymph node metastasis. Significance of lymph node hilar tissue invasion. (1999) (20)
The clinical advantages of I-125 seeds as a substitute for Ir-192 seeds in temporary plastic tube implants. (1989) (20)
Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma. (2011) (20)
Thirty month results with the MammoSite breast brachytherapy applicator: Cosmesis, toxicity and local control in partial breast irradiation (2004) (20)
Shortened Radiation Therapy Schedules for Early‐Stage Breast Cancer: A Review of Hypofractionated Whole‐Breast Irradiation and Accelerated Partial Breast Irradiation (2014) (19)
The Role of Radiation Therapy after Nipple-Sparing Mastectomy (2014) (19)
Accelerated partial breast irradiation utilizing brachytherapy: patient selection and workflow (2016) (19)
On the road to intraoperative radiotherapy: more 'proceed with caution' signs. (2013) (19)
Applying Innovations in Surgical and Radiation Oncology to Breast Conservation Therapy (2005) (18)
Accelerated partial breast irradiation: An update on published Level I evidence. (2016) (18)
The association between very young age and recurrence in the breast in PTS treated with conservative surgery (CS) and radiation therapy (RT) (1990) (18)
Accelerated partial breast irradiation : techniques and clinical implementation (2006) (18)
Refined morphologic criteria for tubular carcinoma to retain its favorable outcome status in contemporary breast carcinoma patients. (2004) (18)
Brachytherapy boost techniques for locally advanced prostate cancer. (1999) (18)
Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy. (2012) (18)
What do recent studies on lumpectomy cavity volume change imply for breast clinical target volumes? (2008) (18)
Practice guideline for the management of ductal carcinoma in-situ of the breast (DCIS). (2007) (18)
Effect of lumpectomy cavity volume change on the clinical target volume for accelerated partial breast irradiation: a deformable registration study. (2010) (17)
Ultrashort courses of adjuvant breast radiotherapy (2012) (17)
Outcomes According to Breast Cancer Subtype in Patients Treated With Accelerated Partial Breast Irradiation (2017) (17)
Cost and Cost-Effectiveness of Image Guided Partial Breast Irradiation in Comparison to Hypofractionated Whole Breast Irradiation. (2019) (17)
Adjuvant Radiotherapy in Early-Stage Breast Cancer: Evidence-Based Options (2016) (17)
Optimal application of the Contura multilumen balloon breast brachytherapy catheter vacuum port to deliver accelerated partial breast irradiation. (2011) (17)
Pathologic and technical considerations in the treatment of ductal carcinoma in situ of the breast with lumpectomy and radiation therapy. (1999) (16)
Partial breast irradiation. Patient selection, guidelines for treatment, and current results. (2007) (16)
Rates of second malignancies after definitive local treatment for ductal carcinoma in situ of the breast. (2011) (16)
Optimal Use of Re-Excision in Patients Diagnosed with Early-Stage Breast Cancer by Excisional Biopsy Treated with Breast-Conserving Therapy (2009) (16)
Unification of a common biochemical failure definition for prostate cancer treated with brachytherapy or external beam radiotherapy with or without androgen deprivation. (2006) (15)
Outcome after ipsilateral breast tumor recurrence in patients with early-stage breast cancer treated with accelerated partial breast irradiation. (2012) (15)
Identifying Patients Whose Symptoms Are Underrecognized During Treatment With Breast Radiotherapy. (2022) (15)
The use of intensity modulated radiation therapy in the treatment of breast cancer: evolving definition, misdirected criticism, and untoward effects. (2004) (15)
MammoSite RTS: The Reporting of Initial Experiences and How to Interpret (2004) (15)
Monomorphic epithelial proliferations: characterization and evidence suggesting they are the pool of partially transformed lesions from which some invasive carcinomas arise. (2007) (15)
Image-Guided Radiation Therapy Committee (2001) (15)
Partial Breast Irradiation (2007) (14)
Outcome after ipsilateral breast tumor recurrence in patients who receive accelerated partial breast irradiation (2012) (14)
Accelerated partial-breast irradiation: trial by media or by science? (2012) (14)
Comparison of Lymphedema in Patients With Axillary Lymph Node Dissections to Those With Sentinel Lymph Node Biopsy Followed by Immediate and Delayed ALND (2013) (14)
Novel radiation therapy approaches for breast cancer treatment. (2020) (13)
The impact of temporary iodine‐125 interstitial implant boost in the primary management of squamous cell carcinoma of the oropharynx (1997) (13)
Use of intensity modulated radiation therapy to reduce acute and chronic toxicities of breast cancer patients treated with traditional and accelerated whole breast irradiation. (2012) (13)
Cost-effectiveness analysis of endocrine therapy alone versus partial-breast irradiation alone versus combined treatment for low-risk hormone-positive early-stage breast cancer in women aged 70 years or older (2020) (13)
Ductal Carcinoma In Situ of the Breast: Evaluating the Role of Radiation Therapy in the Management and Attempts to Identify Low-risk Patients (2015) (13)
Molecular evidence demonstrating local treatment failure is the source of distant metastases in some patients treated for breast cancer. (2008) (13)
Radiation Therapy Oncology Group. Research Plan 2002-2006. Image-Guided Radiation Therapy Committee. (2001) (13)
Breast Movement During Normal and Deep Breathing, Respiratory Training and Set Up Errors: Implications for External Beam Partial Breast Irradiation (2007) (13)
Three-year Clinical Experience Utilizing 3D-Conformal Radiation Therapy to Deliver Accelerated Partial Breast Irradiation (APBI) (2008) (12)
Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy. (2004) (12)
Long-term cosmetic results and toxicity with Accelerated Partial Breast Irradiation (APBI) utilizing interstitial brachytherapy (2003) (11)
Evaluating Candidacy for Hypofractionated Radiation Therapy, Accelerated Partial Breast Irradiation, and Endocrine Therapy After Breast Conserving Surgery: A Surveillance Epidemiology and End Results (SEER) Analysis (2016) (11)
The Role of MRI in the Follow-up of Women Undergoing Breast-conserving Therapy (2016) (11)
Meta-Analysis of Local Invasive Breast Cancer Recurrence After Electron Intraoperative Radiotherapy (2017) (11)
Differences in effective target volume between various techniques of accelerated partial breast irradiation. (2012) (11)
Axillary Failure in Patients Treated with MammoSite Accelerated Partial Breast Irradiation (2011) (11)
Impact of lymph node status on clinical outcomes after accelerated partial breast irradiation. (2012) (11)
Implementation and outcomes of a multidisciplinary high-risk breast cancer program: the William Beaumont Hospital experience. (2012) (10)
Toward Improving Patients' Experiences of Acute Toxicity From Breast Radiotherapy: Insights From the Analysis of Patient-Reported Outcomes in a Large Multicenter Cohort. (2020) (10)
Correlation of Bioimpedance Spectroscopy with Risk Factors for the Development of Breast Cancer-Related Lymphedema (2018) (10)
Advances in Breast Cancer Radiotherapy: Implications for Current and Future Practice. (2021) (10)
The Role of Facility Variation on Racial Disparities in Use of Hypofractionated Whole Breast Radiotherapy. (2019) (9)
The impact of respiration on whole breast radiotherapy: A dosimetric analysis using active breathing control (2000) (9)
Brachytherapy vs whole-breast irradiation for breast cancer. (2012) (9)
Dose-volume analysis of predictors for chronic rectal toxicity following treatment of prostate cancer with high-dose conformal radiotherapy (2003) (9)
Predictors for chronic urinary toxicity following treatment of prostate cancer with 3-d conformal radiotherapy: Dose-volume analysis of a phase II dose escalation study (2004) (9)
Differences in Disease Presentation, Treatment Outcomes, and Toxicities in African American Patients Treated With Radiation Therapy for Prostate Cancer (2012) (9)
Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in early stage breast cancer (1991) (9)
Acute and Chronic Toxicity of Adaptive Image Guided Radiation Therapy (A-IGRT) Delivered With 3D-Conformal Technique (3D-CRT) vs. Intensity Modulation (IMRT) in 728 Prostate Cancer Patients (2007) (9)
The Increasing Role of Lymphedema Screening, Diagnosis and Management as Part of Evidence‐Based Guidelines for Breast Cancer Care (2016) (8)
The Clinical Utility of DCISionRT® on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery (2021) (8)
Two year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons (ASBS) MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI) (2006) (8)
In response to Drs. Kuerer, Pawlik, and Strom (2003) (8)
Recurrence and Survival in the American Society of Breast Surgeons (ASBS) MammoSite ® RTS Registry Trial (2008) (8)
Identifying differences between biochemical failure and cure: incidence rates and predictors. (2011) (8)
Impact of the mode of detection on outcome in breast cancer patients treated with breast-conserving therapy. (1999) (8)
A Modified Phoenix Biochemical Failure (BF) Definition to Account for PSA Bounce Phenomenon for Prostate Cancer Patients Treated with Brachytherapy (BT) (2009) (8)
Strategies for Reducing Cancer Incidence and Mortality in African American and Arab American and Chaldean Communities in the Detroit Metropolitan Area (2012) (8)
Breast Cancer Related Lymphedema: A Review of Recent Developments (2013) (7)
Patient-reported outcomes (PROs) in NRG oncology/NSABP B-39/RTOG 0413: A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) in stage 0, I, or II breast cancer. (2019) (7)
Two cases of liver angiosarcoma among polyvinyl chloride (PVC) extruders of an Italian factory producing PVC bags and other containers. (1984) (7)
Nomogram for predicting the risk of locoregional recurrence in patients treated with accelerated partial-breast irradiation. (2015) (7)
Accelerated treatment of breast cancer: dosimetric comparisons between interstitial HDR brachytherapy, mammosite balloon brachytherapy, and external beam quadrant radiation (2003) (7)
Nomogram for predicting the risk of locoregional recurrence in patients treated with accelerated partial-breast irradiation. (2014) (7)
Intraoperative Radiation Therapy in Breast Cancer: Not Ready for Prime Time (2013) (7)
Axillary lymph node failure in patients treated with accelerated partial breast irradiation (2012) (7)
Potential survival advantage with early androgen deprivation for biochemical failure after external beam radiotherapy: the importance of accurately defining biochemical disease status. (2003) (7)
Three-year Analysis of Treatment Efficacy, Cosmesis and Toxicity by the American Society of Breast Surgeons (ASBS) MammoSite® Breast Brachytherapy Registry Trial in Patients Treated With Accelerated Partial Breast Irradiation (APBI) (2007) (7)
Impact of margin status on outcomes following accelerated partial breast irradiation using single-lumen balloon-based brachytherapy. (2013) (7)
Dedicated cardiac MRI assessment of reduced irradiated left ventricular volume via active breathing control in left sided breast cancer (2004) (7)
Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS) (2021) (7)
Accelerated partial breast irradiation via interstitial brachytherapy as the sole radiation modality for treatment of early-stage breast cancer (2002) (7)
The risk of subclinical breast cancer-related lymphedema by the extent of axillary surgery and regional node irradiation-a randomized controlled trial. (2020) (7)
Low Risk Ductal Carcinoma In Situ (DCIS) Treated with Breast Conserving Surgery & Accelerated Partial Breast Irradation (APBI): Comparison of the Mammosite Registry Trial with Intergroup Study E5194. (2009) (7)
Cosmetic results after conservative surgery, chemotherapy (CTX) and radiation therapy (RT) for early breast carcinoma (1990) (7)
Long-term outcome from RTOG 9517: A phase I/II study of accelerated partial breast irradiation (APBI) with mulitcatheter brachytherapy (MCT) following lumpectomy for early-stage breast cancer. (2012) (7)
Factors associated with chest wall toxicity after accelerated partial breast irradiation using high-dose-rate brachytherapy. (2012) (6)
Comparative Effectiveness Analysis of 3D-Conformal Radiotherapy versus Intensity Modulated Radiotherapy (IMRT) in a Prospective Multicenter Cohort of Breast Cancer Patients. (2021) (6)
COMMENTARY Workshop on Partial Breast Irradiation: State of the Art and the Science, Bethesda, MD, (2004) (6)
A Comparison of Quality of Life for Early Stage Breast Cancer Examining Various Treatment Modalities and NO Chemotherapy (2007) (6)
1079 : Intensity Modulated Radiation Therapy Results in a Significant Decrease in Clinical Toxicities When Compared to Conventional Wedge Based Radiation Therapy (2006) (6)
Outcomes with Partial Breast Irradiation vs. Whole Breast Irradiation: a Meta-Analysis (2021) (6)
High-dose brachytherapy using MammoSite applicator: "Our doubts are traitors, and makes us lose the good we oft might win, by fearing to attempt !". (2007) (6)
Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the CTV (2001) (6)
Most patients are eligible for an alternative to conventional whole breast irradiation for early‐stage breast cancer: A National Cancer Database Analysis (2018) (6)
Two year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons (ASBS) MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). (2006) (6)
Are cosmetic results foliawing conservative surgery (CS) and radiotherapy (RT) dependent on technique (1991) (6)
A Dosimetric Planning Study for Hypofractionated Whole Breast Irradiation with Concurrent Boost (RTOG 1005) for Early Stage Breast Cancer (2011) (6)
Regional Nodal Irradiation: Examining the Clinical Implications of Randomized Trials (2016) (5)
Short Course Breast Radiotherapy (2016) (5)
Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma in Situ (DCIS) of the Breast in a Randomized Clinical Trial (SweDCIS) (2021) (5)
Targeted Intraoperative Radiotherapy for Early Breast Cancer. (2020) (5)
Trends in breast cancer treatment in United States from 2000 to 2011: Consequences of 2004 National Comprehensive Cancer Network (NCCN) guidelines change. (2014) (5)
Delivery of Adjuvant Radiation in 5 Days or Less After Lumpectomy for Breast Cancer: A Systematic Review. (2021) (5)
1069 The use of ultrasonography in the localization of the lumpectomy cavity for low/high dose rate brachytherapy as the sole radiation modality in breast conserving therapy (1995) (5)
Dose Escalation Using Conformal High Dose Rate Brachytherapy Improves the Outcome in Unfavorable Prostate Cancer: 10:36 AM (30) (2002) (5)
Acute and late toxicity in men ≥70 years old compared with men < 70 years old treated with high dose rate prostate brachytherapy boost and pelvic external irradiation for prostate cancer (2001) (5)
Three-Fraction TRIUMPH-T Brachytherapy for Delivery of APBI Offers Effective Disease Control With Minimal Late Toxicity. (2021) (5)
When retrospective comparative effectiveness research hinders science and patient-centered care. (2013) (5)
2006 : Two Year Actuarial Analysis of 198 Patients With DCIS Treated With Accelerated Partial Breast Irradiation (APBI): Efficacy, Cosmesis and Toxicity in Patients on the American Society of Breast Surgeons (ASBS) MammoSite Breast Brachytherapy Registry Trial (2006) (5)
Estimation of Annual Secondary Lung Cancer Deaths Using Various Adjuvant Breast Radiotherapy Techniques for Early-Stage Cancers (2021) (5)
Inconsistency, perspective, double talk, and false virtue. (2003) (5)
A comparison of quality of life (QOL) for patients with early stage breast cancer treated with whole breast irradiation versus targeted partial breast brachytherapy (2003) (5)
Oral PresentationVariability of Target and Normal Structure Delineation for Breast-Cancer Radiotherapy: A RTOG Multi-Institutional and Multi-Observer Study (2007) (5)
The Diminishing Impact of Margin Definitions and Width on Local Recurrence Rates following Breast-Conserving Therapy for Early-Stage Invasive Cancer: A Meta-Analysis (2020) (5)
Integrating partial breast irradiation into surgical practice and clinical trials. (2007) (5)
Intensity-Modulated Radiation Therapy for Breast Cancer (2002) (4)
Can the anatomical location of the prostatic neurovascular bundle and the penile bulb be reliably determined for the purpose of online “nerve-sparing” image-guided radiation therapy in prostate cancer? an MR-CT 3D fusion imaging study (2003) (4)
Regional node failure after conservative surgery (CS) & radiotherapy (RT) for early stage breast carcinoma (1990) (4)
Dose escalation in prostate cancer: a comparison of RTOG chronic toxicities for patients treated in the adaptive external beam process with 3D-conformal or IMRT vs. external beam plus conformal HDR brachytherapy boost (2002) (4)
Ultra-Short Fraction Schedules as Part of De-intensification Strategies for Early-Stage Breast Cancer (2021) (4)
Partial breast irradiation: An updated consensus statement from the American brachytherapy society. (2022) (4)
Acupuncture: Could an ancient therapy be the latest advance in the treatment of lymphedema? (2013) (4)
In regard to Póti et al.: Partial breast irradiation with interstitial (60)co brachytherapy results in frequent grade 3 or 4 toxicity: Evidence based on a 12-year follow-up of 70 patients (Int J Radiat Oncol Biol Phys 2004;58:1022-1033). (2004) (4)
Improvement in Clinical Outcomes with Prostate Radiotherapy at a Single Institution in the PSA Era (2008) (4)
111 Mammographically detected DCIS treated with breast conserving therapy: An analysis of clinical, pathologic, and treatment related factors affecting outcome (1996) (4)
Radiation dose for prostate cancer: is more better? (2006) (4)
Radiation Therapy and the Evolving Definition of Low Risk in Ductal Carcinoma in Situ. (2016) (4)
Modern Approaches for Breast Brachytherapy. (2020) (4)
Ultra-short courses of adjuvant breast radiotherapy: promised land or primrose path? (2012) (4)
Impact of Young Age on Clinical Outcome in Prostate Cancer Treated with High-dose RT in the Modern ERA (2008) (4)
Adaptive Image Guided Radiotherapy (IGRT) Eliminates the Risk of Geometric Miss Due to Rectal Distention in Prostate Cancer Treatment Planning: Biochemical and Clinical Evidence of Efficacy (2008) (4)
Dosimetric Improvements in Balloon Based Brachytherapy Using the Contura® Multi-Lumen Balloon (MLB) Catheter to Deliver Accelerated Partial Breast Irradiation (2010) (4)
Reduction of PTV margin for accelerated partial breast irradiation using on-line detection of surgical clips (2004) (3)
Accelerated partial breast irradiation: 3-dimensional conformal external beam radiotherapy (2006) (3)
126 A technique for dynamic intensity-modulated radiation therapy of the breast using a multi-leaf collimator (1996) (3)
Radiation pneumonitis in breast cancer pts treated with conservative surgery (CS) and radiation therapy (RT) (1990) (3)
Treatment of prostate cancer with goserelin and radiotherapy. (1997) (3)
2280 An efficient method to improve dose uniformity for tangential breast radiotherapy using multiple MLC segments (1999) (3)
NRG RTOG 1005: A Phase III Trial of Hypo Fractionated Whole Breast Irradiation with Concurrent Boost vs. Conventional Whole Breast Irradiation Plus Sequential Boost Following Lumpectomy for High Risk Early-Stage Breast Cancer (2022) (3)
The validity of clips as a radiographic surrogate for the biopsy cavity in image-guided accelerated partial breast irradiation (2003) (3)
Efficacy, Improved Quality of Life, and Cost-effectiveness of Partial Breast Irradiation: A Triple-Threat Approach. (2020) (3)
Accelerated partial-breast irradiation: does the evidence stack up? (2013) (3)
Early outcomes data for accelerated partial breast irradiation using balloon brachytherapy (2011) (3)
Two years experience utilizing moderate deep inspiration breath-hold (MDIBH) to reduce cardiac dose in left sided breast irradiation (2004) (3)
72 Long term outcome of adjuvant whole abdominopelvic radiation therapy for patients with high risk and papillary serous endometrial carcinoma (1995) (3)
Status of Accelerated Partial Breast Irradiation (2010) (3)
Six-year Experience Routinely Utilizing Moderate Deep Inspiration Breath-hold (mDIBH) for Reduction of Cardiac Dose in Left-sided Breast Irradiation for Patients with Both Early-stage and Locally-advanced Breast Cancer (2009) (3)
Treatment of ductal carcinoma in situ. (1999) (3)
Pathologic Anatomy of Early-Stage Breast Cancer and Its Relevance to APBI: Defining the Target (2009) (3)
Partial breast irradiation and the GEC-ESTRO trial (2016) (3)
Three dimensional evaluation of intra- and inter-fraction reproducibility of lung immobilization using active breathing control (2002) (3)
Long-Term Patterns of In-Breast Failure in Patients With Early Stage Breast Cancer Treated With Breast Conserving Therapy: A Molecular Based Clonality Evaluation (2007) (3)
Accelerated partial breast irradiation with the SenoRx balloon brachytherapy catheter: Preclinical treatment planning assessment (2008) (3)
Clinically Achievable Accuracy of Online Localization of the Lumpectomy Cavity Using Surgical Clips (2005) (3)
A Comparison of Quality of Life for Early Stage Breast Cancer Examining Whole Breast IMRT versus Accelerated Partial Breast Irradiation (2010) (3)
Should Ductal Carcinoma In Situ (DCIS) be Removed From the ASTRO Cautionary Group for Off-protocol Use of Accelerated Partial Breast Irradiation (APBI)? A Pooled Analysis of Outcomes for 300 Patients With DCIS treated With APBI (2012) (3)
10 Year Radiotherapy Results for Prostate Cancer Patients Harboring Gleason 7-10, Stage ≥T2b, iPSA ≥20: More and Faster is Better (2008) (3)
Use of a Radiation Tumor Bed Boost Following Breast Conserving Surgery and Whole-Breast Irradiation: Time Trends and Correlates. (2020) (3)
Abstract GS5-01: Appropriate margins for breast conserving surgery in patients with early stage breast cancer: A meta-analysis (2018) (3)
1005 Post operative high dose rate intravaginal irradiation in endometrial cancer: A safe and effective outpatient treatment (1995) (3)
Neuroendocrine carcinoma in conjunction with Gleason score 8-10 prostate cancer: Clinical implications for patients treated with radiotherapy. (2010) (3)
10-year results of interstitial needle-catheter brachytherapy for accelerated partial breast irradiation: Excellent control rates with minimal toxicities (2009) (3)
Set-up inaccuracies in breast irradiation: a comparison of free breathing and Active Breathing Control (ABC) treatment using Electronic Portal Images (EPI) (2003) (2)
Abstract PD5-04: DCIS biosignature reclassified patients who met RTOG 9804 or ECOG-ACRIN E5194 ‘low-risk’ clinicopathologic criteria into an elevated invasive risk group who benefited significantly from radiation therapy (2021) (2)
Biochemical outcomes of treatment for prostate cancer. (2000) (2)
The ABS brachytherapy schools. (2020) (2)
105: A Comprehensive Toxicity Analysis of 1232 Prostate Cancer Patients Treated With Pelvic External Beam Radiotherapy (EBRT) With High Dose Rate (HDR) Brachytherapy Boost, Adaptive EBRT (ART), or Brachytherapy Alone (BT) (2006) (2)
151 Complications and patient satisfaction following breast implant reconstruction with and without radiotherapy (1999) (2)
Abstract OT3-07-01: A randomized trial evaluating bioimpedance spectroscopy vs. tape measurement in the prevention of lymphedema following breast cancer treatment (2017) (2)
Developing a Breast Cancer‐Related Lymphedema Program: The William Beaumont Hospital Experience (2013) (2)
Unification of a common biochemical failure definition across multiple treatment modalities (2004) (2)
Reducing chronic breast cancer related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy (BIS). (2017) (2)
Regional Nodal Irradiation: Moving Beyond Overall Survival. (2016) (2)
Long-term Update of RTOG 0319: A Phase 1/2 Trial to Evaluate 3-Dimensional Conformal Radiation Therapy (3D-CRT) Confined to the Region of the Lumpectomy Cavity for Stage I and II Breast Carcinoma (BrCa) (2013) (2)
Abstract P5-15-02: Evaluating the cost of endocrine therapy vs. radiation therapy alone for low risk hormone positive early stage breast cancer in elderly patients (2019) (2)
Reduction in heart and lung doses using deep inspiration breath hold with active breathing control for patients treated with loco regional breast irradiation including the internal mammary nodes (2002) (2)
Comment on: ‘Increases in arm volume predict lymphoedema and quality of life deficits after axillary surgery: a prospective cohort study.’ (2021) (2)
3D Conformal External Beam Technique (2009) (2)
Cardiac Avoidance in Breast Radiotherapy: Many Choices for a Worthwhile Objective (2014) (2)
40 Accelerated treatment of breast cancer: The william beaumont hospital experience (2000) (2)
Disease Control After Hypofractionation Versus Conventional Fractionation for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational Cohort. (2021) (2)
116 Overcoming internal prostatic motion and set-up inaccuracies with conformal interstitial brachytherapy (1995) (2)
Partial-Breast Irradiation: Review of Modern Trials (2019) (2)
Monomorphic epithelial proliferations of the breast: a possible precursor lesion associated with ipsilateral breast failure after breast conserving therapy in patients with negative lumpectomy margins. (2011) (2)
Improved Outcome with Combined Pelvic External Beam Radiation and HDR Boost Brachytherapy or IMART Compared with Conventional External Beam Prostate Radiation for Elderly Men with High-intermediate to High-risk Prostate Cancer (2009) (2)
Inconsistency, perspective, double talk, and false virtue. (2002) (2)
Accelerated partial breast irradiation—Redefining the treatment target for women with early stage breast cancer (2019) (2)
Evaluation of Dose Accuracy in the Near-Surface Region for Whole Breast Irradiation Techniques in a Multi-Institutional Consortium. (2022) (2)
Comparative Analysis of the Efficacy of Three Forms of Accelerated Partial Breast Irradiation from a Single Institution (2009) (2)
Dosimetric evaluation of two multileaf collimator conformation strategies for irregular fields (1994) (2)
Reducing rates of chronic breast cancer–related lymphedema with screening and early intervention: an update of recent data (2022) (2)
Bioimpedance spectroscopy for lymphedema assessment: Clinical practice guidelines. (2016) (2)
Should screening MRI be included in surveillance for patients treated with breast-conserving therapy? (2009) (2)
1 On-line conformal HDR dose escalation trial in prostate cancer (1996) (2)
Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer. (1999) (2)
CONSENSUS STATEMENT: APBI FROM ASTRO (2010) (2)
Radiation Therapy Oncology Group. Research Plan 2002-2006. Breast Cancer Working Group. (2001) (2)
The Use of Molecular Assays to Definitively Establish the Clonality of Ipsilateral Breast Tumor Recurrences in Patients With Early Stage Breast Cancer Treated With Breast Conserving Therapy (2005) (2)
Intracavitary balloon brachytherapy for breast cancer: Surgical considerations. Authors' reply (2003) (2)
A planning comparison of seven irradiation options allowed in RTOG 1005 for early stage breast cancer (2015) (2)
American brachytherapy society radiation oncology alternative payment model task force: Quality measures and metrics for brachytherapy. (2021) (2)
Optimal reporting of treatment outcome after external beam radiation therapy for prostate cancer (1998) (2)
Mediators of Racial Disparities in Heart Dose among Whole Breast Radiotherapy Patients. (2022) (1)
A Two Year Comparison of Quality of Life for Early Stage Breast Cancer Patients Treated with Whole Breast IMRT with and without Chemotherapy (2008) (1)
Is excision alone adequate for low-risk DCIS of the breast treated with breast conserving therapy (2014) (1)
The American Society of Breast Surgery MammoSite Registry: Factors Associated with Optimal Long-term Cosmetic Results (2011) (1)
Rates of Secondary Primary Cancers after Definitive Treatment for Prostate Cancer using Modern Radiation Therapy Techniques (2009) (1)
Cost-Effectiveness Analysis of No Adjuvant Therapy Versus Partial Breast Irradiation Alone Versus Combined Treatment for Treatment of Low-Risk DCIS: A Microsimulation. (2021) (1)
137 The effects of androgen deprivation on patients with locally advanced prostate cancer treatment with external beam radiotherapy plus conformal high dose rate brachytherapy boost (2000) (1)
Partial breast irradiation: Accelerated and intraoperative accelerated and intraoperative (2018) (1)
A novel biosignature to assess residual risk in ductal carcinoma in situ (DCIS) patients after standard treatment. (2020) (1)
Biochemical control and acute toxicity associated with high dose rate conformal boost brachytherapy for prostate cancer: Comparison of three-implant vs two-implant regimes (1998) (1)
RADIATIN PNEUNONITIS IN BREAST CANCER PATIENTS TREATED WITH CONSERVATIVE SURGERY AND RADIATION THERAPY (1991) (1)
Outcomes for Accelerated Partial Breast Irradiation in Ductal Carcinoma In Situ Patients (2010) (1)
The choice of IMRT for early-stage right breast cancer. (2013) (1)
1090 : A Comparison of Treatment Efficacy, Toxicity and Cosmetic Results Employing Four Different Accelerated Partial Breast Irradiation Techniques (2006) (1)
A comparison of external beam radiation combined with HDR IR-192 boost brachytherapy vs radical prostatectomy for patients with intermediate to high risk prostate cancer (2002) (1)
Highlights of surgery and radiotherapy (2002) (1)
The influence of percentage of preradiation needle biopsies with adenocarcinoma and total radiation dose on the pathologic response of unfavorable prostate adenocarcinoma. (2002) (1)
Minimizing toxicity in breast irradiation (2017) (1)
Percentage of positive biopsy cores to predict distant metastasis of prostate cancer after definitive radiation therapy. (2011) (1)
Improved quality of life following breast conserving therapy for early stage breast cancer (2003) (1)
OC-90 EFFICACY OF YOUNG PATIENTS TREATED WITH ACCELERATED PARTIAL BREAST IRRADIATION FOR EARLY-STAGE BREAST CANCER (2012) (1)
Clinical Implication of PSA Bounce After Treatment of Prostate Cancer with Brachytherapy and/or External Beam Radiotherapy with or Without Androgen Deprivation (2005) (1)
3-Year Follow-Up of the Partial Breast Irradiation Trial for DCIS Using the MammoSite® Brachytherapy Balloon Catheter. (2009) (1)
Interim Analysis of Treatment Efficacy, Cosmesis and Toxicity Using the MammoSite™ Breast Applicator to Deliver Accelerated Partial Breast Irradiation (2007) (1)
Factors Associated With Optimal Cosmetic Results at 60 Months in Patients Treated With Accelerated Partial Breast Irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial (2011) (1)
An Analysis of Rapid Review Cases That Failed to Meet the RTOG 1005 Contouring and Dose–Volume Criteria (2013) (1)
Does brachytherapy reduce morbidity compared to external beam adaptive radiotherapy or pelvic irradiation with brachytherapy boost for localized prostate cancer (2008) (1)
Overview of Outcomes with Accelerated Partial Breast Irradiation (2016) (1)
An Estimate of Local Failure in the TARGIT-A Trial of Pre-pathology Intraoperative Radiation Therapy for Early Breast Cancer. (2022) (1)
113 The use of radiotherapy in the conservative management of pager's disease (1996) (1)
10 Year Outcomes for Regional Nodal Failure in Early Stage Breast Cancer Patients Treated with Breast Conserving Therapy (2009) (1)
Current Diagnostic Tools for Breast Cancer-Related Lymphedema (2023) (1)
Stereotactic Partial Breast Irradiation: What Does the Future Hold? (2022) (1)
Optimal patient selection for electron intraoperative radiotherapy (IORT) as sole treatment for breast cancer. (2016) (1)
SU‐FF‐T‐37: Contura Multilumen Balloon (MLB) Registry Trial: Initial Dosimetric Experience (2009) (1)
The Credentialing Process for the NSABP B-51/RTOG 1304 Phase 3 Randomized Clinical Trial (2014) (1)
2046 Irradiation of the tumor bed alone after lumpectomy in selected patients with early stage breast cancer treated with breast conserving therapy (1997) (1)
Utilization and Toxicity of Breast Boost Radiation Therapy Following Hypofractionated Whole Breast Irradiation: Comparative Analysis of a Large, Statewide Multicenter Cohort (2018) (1)
Regional nodal irradiation following pathologic complete response in the axilla to neoadjuvant chemotherapy: patterns of treatment (2017) (1)
Iodine-125 temporary interstitial implants and limb-conserving surgery in the management of extremity soft-tissue sarcomas (1996) (1)
90 The impact of young age on outcome in patients with ductal carcinoma in situ treated with breast-conserving therapy (1999) (1)
A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy. (2022) (1)
An Update of the Credentialing Process for the NRG Oncology NSABP B-51 / RTOG 1304 Phase 3 Randomized Clinical Trial (2015) (1)
Improved Survival With Negative Margins and Postoperative Radiotherapy for Merkel Cell Carcinoma (2007) (1)
Correction to: The Clinical Utility of DCISionRT® on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery (2021) (1)
Comprar Accelerated Partial Breast Irradiation · Techniques and Clinical Implementation | Wazer, David E. | 9783540880059 | Springer (2009) (1)
A novel biosignature identifies DCIS patients with a poor biologic subtype with an unacceptably high rate of local recurrence after breast conserving surgery and radiotherapy. (2021) (1)
The Michigan Radiation Oncology Quality Consortium: A Novel Initiative to Improve the Quality of Radiation Oncology Care. (2022) (1)
Prognostic significance of tumor histology of recurrence in the treated breast after conservative surgery (CS) and radiation therapy (RT) for early-stage breast cancer (1991) (1)
High-Dose-Rate Re-Irradiation with Continuous Hyperthermia for Recurrent Prostate Cancer (2010) (1)
Initial dosimetric experience: Contura™ Multilumen Balloon Registry Trial (2009) (1)
Patterns of failure observed in the two-step institution credentialing process for NRG Oncology/RTOG 1005 (NCT01349322) and lessons learned. (2019) (1)
236 - Clinical implementation of adaptive radiation therapy (1995) (1)
Abstract GS3-07: Identifying patients whose symptoms are under-recognized during breast radiotherapy: Comparison of patient and physician reports of toxicity in a multicenter cohort (2021) (1)
Phase I/II study evaluating early tolerance in breast cancer patients undergoing accelerated partial breast irradiation treated with MammoSite balloon breast brachytherapy catheter using a two-day dose schedule. (2009) (1)
1078 The role of regional nodal irradiation in the management of patients with stage I and II breast cancer treated with breast conserving therapy (1995) (1)
A matched-pair analysis of dose-escalated adaptive image-guided radiotherapy (IGRT) versus pelvic irradiation with brachytherapy boost for intermediate- and high-risk prostate cancer. (2010) (1)
Is the 1 cm CTV Margin Used in Breast Balloon Brachytherapy Equivalent to a 1.5 cm CTV Margin in External Beam Partial Breast Irradiation? A Deformable Registration Study (2010) (1)
165 Factors associated with local recurrence of mammographically-detected ductal carcinoma in situ treated with breast-conserving therapy (1999) (1)
Does local recurrence affect the rate of distant metastases and survival in patients with early stage breast cancer treated with breast conserving therapy (2001) (1)
P3-13-04: Functional and Cosmetic Outcomes Following Post-Mastectomy Irradiation with Tissue Expander/Implant Reconstruction. (2011) (1)
Comparative Analysis of Two Distinct Time-Dose-Fractionation Schemes [2-Day Vs 5-Day] for Delivery of Accelerated Partial Breast Irradiation via the MammoSite® RTS Applicator (2010) (1)
CONSENSUS PANEL GUIDELINES ON THE USE OF ACCELERATED PARTIAL BREAST IRRADIATION (2011) (1)
Documenting Treatment Cure in Prostate Cancer Patients Treated with Radiation Therapy: How and When (2011) (0)
Predictors of Long Term Toxicity of Three-dimensional Conformal Radiotherapy for Accelerated Partial Breast Irradiation (2010) (0)
The impact of ipsilateral breast tumor recurrence on cause specific survival in DCIS patients treated with breast conserving therapy or mastectomy (2004) (0)
The value of performance metrics in a large statewide consortium: using planning target volumes towards improvements in breast planning. (2018) (0)
Analysis of Biochemical Failure Definitions Based on Absolute and Current Nadir Methodologies and Their Integration with Prostate-Specific Antigen (PSA) Doubling Time (2005) (0)
2252 : Adaptive Image-Guided Radiotherapy (A-IGRT) vs. Conformal Image-Guided Brachytherapy (C-IGBT) for Favorable Risk Prostate Cancer (2006) (0)
Outcomes and Toxicities of 3-dimensional Conformal Accelerated Partial Breast Irradiation (2012) (0)
A dose selection-escalation trial using the adaptive radiotherapy process (ART) in localized prostate adenocarcinoma: acute toxicity (2001) (0)
Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines (2022) (0)
Long-term Follow-up at a Single Institution in Patients with Ductal Carcinoma-in-situ (DCIS) of the Breast Treated with Breast Conserving Therapy (BCT) or Mastectomy (2008) (0)
Patterns of Failure Observed in the 2-Step Institution Credentialing Process for NRG Oncology/Radiation Therapy Oncology Group 1005 (NCT01349322) and Lessons Learned (2020) (0)
Accelerated partial breast irradiation (APBI): A less toxic breast cancer treatment technique underutilized in the Hispanic population. (2015) (0)
Percentage of Positive Biopsy Cores is a Strong Predictor of Clinical Outcome and Overall Survival in Prostate Cancer (2009) (0)
Increasing use of Hypofractionated Whole Breast Irradiation: An Analysis of Practice Patterns within a State-Wide Quality Consortium (2018) (0)
Abstract PD6-6: Identifying patients at higher risk of toxicity after breast radiotherapy: Analysis of patient-reported outcomes in the Michigan Radiation Oncology Quality Consortium cohort (2020) (0)
Re-Thinking Clinicopathologic Risk Assessment in DCIS: Pooled Data from Validation Studies Comparing a 7-gene DCIS Assay to Clinicopathologic Features Alone (2022) (0)
Abstract P4-16-03: Patterns of failure after accelerated partial breast irradiation by consensus panel group: A pooled analysis of William Beaumont Hospital and the American Society of Breast Surgeons Trial data (2012) (0)
Utilization of bioimpedance spectroscopy (BIS) to reduce rates of breast cancer related lymphedema (BCRL) in extremely high-risk patients. (2018) (0)
Low Risk of Regional Recurrence in Merkel Cell Carcinoma with Post-operative Radiation and Negative Sentinel Lymph Node Biopsy (2008) (0)
1022 poster IMPACT OF ANDROGEN DEPRIVATION ON THE PROGNOSTIC VALUE OF NEUROENDOCRINE DIFFERENTIATION FOR HIGH GRADE PROSTATE CANCERS TREATED WITH RADIOTHERAPY (2011) (0)
Assessing the benefit of adjuvant endocrine therapy in patients following breast-conserving surgery with or without radiation stratified by a 7-gene predictive DCIS biosignature. (2022) (0)
IN REGARD TO CHEN ET AL. (INT J RADIA T ONCOL BIOL PHYS 2007;69:25-31) AND CHAO ET AL. (INTJRADIATONCOL BIOL PHYS 2007;69:32-40). Authors' reply (2008) (0)
The impact of chemotherapy on toxicity and cosmetic outcome in patients receiving whole breast irradiation: an analysis within a state-wide quality consortium. (2022) (0)
A fully automatic framework for evaluating cosmetic results of breast conserving therapy (2022) (0)
The Cost of Simplicity for Early-stage Breast Cancer Treatment. (2022) (0)
Whole Breast IMRT Using Inverse Planning: Optimizing Dose Homogeneity With Preferential Sparing of Normal Tissues (2007) (0)
Abstract P5-08-15: Reducing Rates of Chronic Breast Cancer Related Lymphedema with Screening & Early Intervention: An Update of Recent Data (2023) (0)
Long term update of NRG Oncology RTOG 0319: A Phase I/II Trial to Evaluate Three Dimensional Conformal Radiation Therapy (3D-CRT) Confined to the Region of the Lumpectomy Cavity for Stage I and II Breast Carcinoma (2017) (0)
Hypofractionated Online Cone-beam CT-guided Intensity Modulated Radiation Therapy (hypoCBCT-IMRT) for Localized Prostate Cancer: Acute Toxicity Profile Compared to Adaptive Offline Image-guided IMRT (ART-IMRT) (2010) (0)
Radiotherapy and Ductal Carcinoma in Situ (2009) (0)
Abstract P2-11-13: Meta-analysis of local recurrence of invasive breast cancer after electron intraoperative radiotherapy (2018) (0)
Comparing the Effectiveness of Low Dose Rate Brachytherapy, High Dose Rate Brachytherapy and Intensity Modulated Radiation Therapy for the Treatment of Low/Intermediate Risk Prostate Cancer (2011) (0)
Equivalent Incidence of Second Malignancies after Definitive Treatment for Ductal Carcinoma In Situ: A Matched Pair Analysis of Surgery and Radiation vs. Surgery Alone (2010) (0)
Consistent Skin and Rib Dose Reduction Using the Contura Multi-Lumen Balloon (MLB) Breast Brachytherapy Catheter: Preliminary Dosimetric Findings of a Phase II Trial (2009) (0)
1100 Black Race is Associatedwith Higher Riskof LocoregionalRecurrence after Breast-conserving Therapy in Patients with Triple Negative Breast Cancer (2011) (0)
A Novel Biosignature to Assess Residual Risk in Early Stage Invasive Breast Cancer after Standard Breast Conserving Surgery (2020) (0)
Is the Phoenix Biochemical Failure Definition Accurate for Prostate Cancer Patients Treated with Brachytherapy Alone (2010) (0)
168 Ongoing clinical experience utilizing moderate Deep Inspiration Breath-hold (mDIBH) to reduce cardiac dose in left sided breast irradiation (2005) (0)
Anatomic Pathology / IPSILATERAL BREAST FAILURE AND DISTANT METASTASES AFTER BREAST-CONSERVING THERAPY (2003) (0)
Author reply (0)
Limited-field and whole-breast hypofractionated radiotherapy: additional considerations. (2012) (0)
Pathologic Anatomy of Early-Stage Breast Cancer and its Relevance to Accelerated Partial Breast Irradiation: Defining the Target (2006) (0)
Abstract P2-13-15: Factors associated with triggering events on the PREVENT trial at 2 years post-operatively (2020) (0)
Follow-up (Months) % Local recurrence (2008) (0)
Lobular Carcinoma in Situ (LCIS) in Association with Invasive Breast Cancer: Does LCIS Predict for Local Recurrence? (2005) (0)
Risk factors for axillary failure in patients with early stage breast cancer managed with accelerated partial breast irradiation using the MammoSite® breast brachytherapy catheter (2009) (0)
Local control, toxicity and cosmesis in women younger than 50 enrolled on the american society of breast surgeons mammosite® RTS registry trial (2008) (0)
Who is a Candidate for Accelerated Partial Breast Irradiation (2006) (0)
Excellent Ten-Year Results following Accelerated Partial Breast Irradiation with Multicatheter Interstitial Brachytherapy in Unsuitable Patients as Categorized by the American Society of Therapeutic Radiology and Oncology Consensus Panel (2010) (0)
American Society of Breast Surgeons MammoSite® Registry: Ductal carcinoma in-situ subset – three-year data in 194 cancers (2008) (0)
Implementation of a BCRL management programme (2011) (0)
Evaluation of current consensus panel guidelines for APBI: A pooled analysis of William Beaumont Hospital and American Society of Breast Surgeons MammoSite registry trial data. (2012) (0)
Impact of Evolving Margin Definitions Following Breast Conserving Surgery on Boost Utilization (2020) (0)
In Reply to Ling and Beriwal. (2022) (0)
1070 The role of total dose in conservative surgery and radiation therapy for early stage breast cancer: Is there a critical level? (1995) (0)
Factors affecting survival in women with ductal carcinoma in situ (DCIS): Race and the delivery of adjuvant radiotherapy. (2016) (0)
The use of dose volume constraints to achieve rectal isotoxicity: A phase II prostate cancer radiation therapy dose escalation study. (2004) (0)
2248 : Adaptive Image-Guided Radiotherapy (IGRT) vs. Pelvic RT + Image-Guided High-Dose-Rate (HDR) Brachytherapy Boost for Intermediate & High Risk Prostate Cancer (2006) (0)
Age and Grade as a Function of Decision Score in Women Diagnosed with DCIS (2020) (0)
The use of bioimpedance spectroscopy to monitor response to treatment interventions with breast cancer-related lymphedema. (2013) (0)
Cost-Effectiveness Analysis of Ultra-Short Whole Breast Radiation Therapy Alone vs. Endocrine Only or Combined Treatment for Low-Risk ER-Positive Early-Stage Breast Cancer in Women Age 70 and Older (2022) (0)
Long-term Cosmesis and Toxicity Profile Following Accelerated Partial Breast Irradiation (APBI): Final Analysis of the American Society of Breast Surgeons Breast Brachytherapy Registry Trial (2013) (0)
The impact of lymph node status on clinical outcomes following accelerated partial breast irradiation. (2011) (0)
Race as a “Risk Factor” to Receive More Aggressive Treatments in Breast Cancer Patients - An Analysis From the National Cancer and the Surveillance, Epidemiology, and End Results Program Databases (NCDB, SEER) From Years 2000 to 2011 (2015) (0)
Intermediate-Term Outcomes and Toxicity for Phase I/II Study Evaluating Breast Cancer Patients Undergoing Accelerated Partial Breast Irradiation With the MammoSite Radiation Delivery System Using a Two-Day Dose Schedule (2011) (0)
Abstract182 Adaptive interstitial HDR breast implants (1996) (0)
OC-92 IMPACT OF MARGIN STATUS AFTER APBI: AN ANALYSIS OF THE AMERICAN SOCIETY OF BREAST SURGEONS MAMMOSITEEE REGISTRY TRIAL (2012) (0)
2060 Clinical and pathologic factors predictive of biochemical control following post-prostatectomy irradiation (1996) (0)
In Reply to Chuba and Aref. (2016) (0)
Neuroendocrine Carcinoma in Conjunction with Gleason Score 8-10 Prostate Cancer: Clinical Implications for Patients Treated with Radiotherapy (2010) (0)
(P006) Care Pathway Alternatives for Early Stage Breast Cancer Radiotherapy: A National Cancer Database Analysis (2017) (0)
[Experimental studies on modifying capacity of largactil in paralyzing effect of curare]. (1955) (0)
Abstract 2764: Creating a review process of a digital photo database collected on NRG NSABP B39/RTOG 0413 phase III clinical trial for evaluation of cosmetic results from breast conserving therapy (BCT) (2017) (0)
In Response to Dr. Yaeger (2008) (0)
Abstract P3-05-29: Use of Bioimpedance Spectroscopy as a Surrogate for Bone Mineral Content in Oncology Patients: Practical Application of the SOZO Device (2023) (0)
Is There Justification for the Utilization of IMRT in the Treatment of Early-Stage Right Breast Cancer? (2013) (0)
Abstract P3-17-03: Raising the level of cancer care around the world: The feasibility and perceived benefit of a virtual breast tumor board (2022) (0)
P3-13-09: Impact of Estrogen Receptor Negativity on Clinical Outcomes Following Accelerated Partial Breast Irradiation. (2011) (0)
Six-Year Outcomes for Phase 1/2 Study Evaluating Hypofractionated Accelerated Partial-Breast Irradiation Using a 2-Day Dose Schedule (2013) (0)
DCIS Managed with BCS: Whole-Breast XRT vs. Partial Breast XRT (2015) (0)
1078: A Novel Inverse-Planned 5-field Intensity Modulated Radiation Therapy (IMRT) Technique for Regional Nodal Breast Irradiation (2006) (0)
The role of mammographic and pathologic findings in optimizing local control for breast cancer patients with infiltrating lobular carcinoma treated with conservative surgery and radiation therapy (1992) (0)
Regarding Sequencing of Androgen-Deprivation Therapy. (2023) (0)
Cost-Effectiveness of Endocrine Therapy Alone versus Partial Breast Irradiation Alone versus Combined Treatment for Women Age ≥70 With Low-Risk Hormone-Positive Early Stage Breast Cancer (2020) (0)
Factors Associated with Patient-Reported and Physician-Assessed Acute Toxicity after Hypofractionated Breast Radiotherapy, a Report from a Large Multi-Center Cohort Study (2019) (0)
Six-year Analysis of Treatment-related Toxicities by the American Society of Breast Surgeons MammoSi (2011) (0)
Accelerated T reatment o f B reast C ancer (2001) (0)
Limited-Field and Whole-Breast Hypofractionated Radiotherapy (2012) (0)
Comparing the Costs of Robotic Prostatectomy and Radiation Therapy in Intermediate-Risk Prostate Cancer: Impact of the AUA/ASTRO Guidelines (2015) (0)
Early Stage, But Not So Routine. (2020) (0)
Is Partial Breast Irradiation a Safe and Effective Treatment Approach for Women with Early-Stage Breast Cancer? (2013) (0)
Abstract B016: Guiding de-escalation of treatment for patients with DCIS using a predictive 7-gene biosignature: Identification of a clinically low-risk patient group (2022) (0)
Dose-Escalated Adaptive Image-Guided Radiotherapy Versus Pelvic Irradiation With High-Dose-Rate Brachytherapy Boost for High-Risk Prostate Cancer (2011) (0)
The MammoSite Technique for Accelerated Partial Breast Irradiation (2009) (0)
P3-13-02: The Impact of Lymph Node Status on Clinical Outcomes Following Accelerated Partial Breast Irradiation. (2011) (0)
Abstract P6-12-03: Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer related lymphedema (2018) (0)
Are We Missing Acute Toxicities Associated with Hypofractionated Breast Irradiation? A Report from a Large Multi-Center Cohort Study (2019) (0)
Abstract PS6-17: Clinical utility of a biologic signature to assess DCIS recurrence risk in patients meeting ‘good-risk’ criteria (RTOG 9804, ECOG 5194): Interim analysis of the DCISionRT PREDICT study (2021) (0)
Abstract PD4-07: Contemporary practice patterns for the use of regional nodal irradiation during post-lumpectomy radiotherapy for patients with N0/N1 breast cancer (2021) (0)
Radiation Oncology in Breast Cancer (2013) (0)
The Risk of Subclinical Breast-Cancer Related Lymphedema (BCRL) by the Extent of Surgery and Regional Node Irradiation (RNI)—a Randomized Controlled Trial (2020) (0)
Abstract P1-05-16: Bioimpedance Spectroscopy Monitoring Reduces Long-term Clinical Lymphedema Risk (2023) (0)
Short-Course Accelerated Partial Breast Irradiation (Over 2 Days) Is Feasible With the Contura® Multi-Lumen Brachytherapy Device (2011) (0)
The increasing role of breast cancer lymphedema screening, diagnosis, and management as part of evidence-based breast cancer survivorship. (2016) (0)
Trends in Close Margin Status and Radiation Therapy Boost in Early Stage Breast Cancer Treated with Breast Conserving Therapy (2020) (0)
Factors associated with local recurrence in patients with mammographically-detected DCIS treated with conservative surgery with or without radiation therapy (1998) (0)
Treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy applicator for the delivery of accelerated partial breast irradiation (2008) (0)
Propensity-score matched pair comparison of brachytherapy-based accelerated partial breast irradiation versus whole breast Canadian hypofractionation. (2013) (0)
Reflecting on CRISPR Gene Editing (2019) (0)
2058 Re-analysis of clinical and treatment related prognostic factors on outcome using biochemical control as an end-point in patients with prostate cancer treated with external beam irradiation (1996) (0)
152 Comparison of chronic toxicities for prostate cancer patients treated with external beam irradiation or permanent PD-103 implants (2000) (0)
Predictors of cosmesis in women enrolled on the American Society Of Breast Surgeons MammoSite® Registry Trial (2008) (0)
Abstract P3-15-07: Late Toxicity and Patient Self-Assessment of Breast Appearance/Satisfaction on RTOG 0319: A Phase II Trial of Three Dimensional Conformal Radiation Therapy (3DCRT) Partial Breast Irradiation (PBI) Following Lumpectomy for Stage I and II Breast Cancer (2010) (0)
A comparison of quality of life of early stage breast cancer patients treated by brachytherapy alone versus external beam radiation (1998) (0)
Abstract P4-16-09: Dosimetric feasibility and acute toxicity in a prospective trial of ultra-short course accelerated partial breast irradiation (APBI) using a multi-lumen balloon brachytherapy device (2012) (0)
Consistent Reductions in Skin Doses Using the Contura™ Multi-Lumen Balloon Breast Brachytherapy Catheter to Deliver Accelerated Partial Breast Irradiation (2010) (0)
II mage-Detected Breast Cancer : State of the Art iagnosis and Treatment (2005) (0)
A matched-pair analysis of interstitial brachytherapy versus external beam irradiation in the treatment of patients with low risk prostate cancer at a single institution (2000) (0)
Measuring quality of life of breast cancer patients when treated by breast conserving techniques (2001) (0)
Initial Dosimetric Experience with the Contura Multi-lumen Radiation Balloon Applicator (2008) (0)
57 The role of brachytherapy in the treatment of breast cancer: The American Brachytherapy Society Recommendations (2001) (0)
Ethnic Differences in Disease Presentation, Management Techniques and Treatment Outcome in Patients Treated with Breast Conserving Therapy for Early Stage Breast Cancer (2008) (0)
Poster Viewing AbstractOutcomes of Breast Cancer Patients with Triple Negative Receptor Status Treated with Accelerated Partial Breast Irradiation (2010) (0)
Utilization of breast preservation treatments in Hispanic patients with breast cancer: An analysis from the National Cancer Data Base (NCDB) from 2000 to 2011. (2014) (0)
Accelerated Partial-Breast Irradiation: Outcomes and Future Perspectives (2015) (0)
Abstract B33: Reducing the ethnic/minority cancer burden in communities in S.E. Michigan utilizing a community‐based participatory process (2010) (0)
Comparing clinical outcomes of adaptive image-guided radiotherapy (A-IGRT) vs. conformal image-guided brachytherapy (C-IGBT) for favorable risk prostate cancer (2007) (0)
ePoster SessionsLessons Learned From the Two-Step QA Process in NRG Oncology/RTOG 1005, A Phase 3 Trial for Early-Stage Breast Cancer (2017) (0)
Time to Revise the Consensus Statement Guidelines for the Use of Accelerated Partial Breast Irradiation Off Protocol (2011) (0)
Tailored Radiotherapy for Breast Cancer Stages I and II: Technical Aspects (2006) (0)
Clonality of Post-radiation and Post-prostatectomy Adenocarcinomas: Some Local Recurrences are Second Primary Neoplasms (2008) (0)
[Brief considerations on the R. Gille mosaic test]. (1967) (0)
In Reply to Chow and Simone. (2022) (0)
Factors Associated with Skin Telangectasias and Cosmetic Outcome in Patients Treated on the American Society of Breast Surgeons MammoSite Registry Trial (2008) (0)
Molecular evidence demonstrating that local treatment failure is the source of distant metastases in some patients treated for breast cancer (2008) (0)
Abstract P3-14-08: The impact of a structured surveillance protocol using bioimpedance spectroscopy (BIS) on preventing breast cancer related lymphedema (BCRL) in high-Risk patients (2018) (0)
P65 MammoSite Radiation Therapy System (RTS) as theSole Radiation Technique for DCIS of the Breast after Lumpectomy: A Phase II Trial (2005) (0)
Breast Brachytherapy: Intracavitary Breast Brachytherapy (2016) (0)
Increasing total and biologically active chromium in wheat grain and spinach by spraying with chromium salts (1981) (0)
2056 The impact of irradiation dose and margin status on the outcome of stage I and II breast cancer patients treated with breast conserving therapy (1999) (0)
Efficacy analysis of high-risk breast cancer patients treated with accelerated partial breast irradiation from a single institution. (2011) (0)
628 poster SHORT-COURSE ACCELERATED PARTIAL BREAST IRRADIATION (OVER 2 DAYS) IS FEASIBLE WITH THE CONTURA(r) MULTI-LUMEN BRACHYTHERAPY DEVICE (2011) (0)
Combined ultrasound 1hyperthermia and irradiation for the treatment of chest wall recurrences following mastectomy in heavily pretreated patients with carcinoma of the breast (1993) (0)
Short Course Accelerated Hypofractionated Partial Breast Balloon Brachytherapy (2018) (0)
Abstract P3-18-01: Assessmentof DCISionRT for guiding radiotherapy of DCIS in Sweden (2022) (0)
Review of Two-Year Analysis of the MammoSite Breast Brachytherapy Registry Trial (2007) (0)
[Observations on the therapeutic use of largactil]. (1955) (0)
Abstract P3-14-09: Low rates of chronic breast cancer related lymphedema (BCRL) in a cohort of high-Risk patients undergoing prospective surveillance with bioimpedance spectroscopy (BIS) (2018) (0)
Chapter 60 – Noninvasive Breast Cancer (2012) (0)
S31 Treatment of local reappearance of breast cancer (2011) (0)
Abstract PD15-07: PD15-07 7-gene predictive biosignature improves risk stratification for breast ductal carcinoma in situ patients compared to clinicopathologic criteria, identifying a low risk group not clinically benefiting from adjuvant radiotherapy (2023) (0)
External Beam Adaptive Radiation Therapy (ART) on a Conventional Medical Accelerator (2006) (0)
The impact of radiation modality and poor prognostic factors on clinical outcome for prostate cancer (2001) (0)
Three year analysis of patient demographics, treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite® registry in patients (age <50 or ≥ 50) treated with accelerated partial breast irradiation (APBI). (2009) (0)
75 oral TWELVE YEAR CLINICAL OUTCOMES WITH INTERSTITIAL ACCELERATED PARTIAL BREAST IRRADIATION (2011) (0)
Clinical Outcomes in Patients Treated With Accelerated Partial Breast Irradiation Versus Whole-Breast Irradiation: Results of Two Matched Pair Analyses (2011) (0)
Changes in patterns of local failure after long-term follow-up with breast-conserving therapy (2003) (0)
Quality Improvement in a Statewide Collaborative Radiation Oncology Quality Consortium. (2021) (0)
P3-13-01: Boost Radiation Therapy Not of Value in Reducing IBTR of Invasive or Noninvasive Breast Cancers for Patients with DCIS: Results from the NSABP B-24 Trial. (2011) (0)
Outcomes and Toxicities with Partial Breast Irradiation vs. Whole Breast Irradiation: A Meta-Analysis (2020) (0)
1028 poster IS THERE A BENEFIT OF HORMONAL THERAPY FOR PATIENTS WITH HIGH RISK PROSTATE CANCER IN THE ERA OF DOSE-ESCALATED IMAGE-GUIDED RADIATION THERAPY (2011) (0)
Maximum Skin Dose as a Predictor of Toxicity from MammoSite Brachytherapy (2008) (0)
Comparison of Five Year Clinical Outcomes between Interstitial, Balloon-Based, and 3-D Conformal Partial Breast Irradiation Techniques in ASTRO Suitable and Cautionary Risk Category Patients (2011) (0)
Pilot study evaluating early tolerance in patients undergoing accelerated partial breast irradiation (APBI) treated with MammoSite® using a two-day dose schedule (2006) (0)
2002 Long-term outcome in mammographically detected invasive breast cancer treated with breast conserving therapy (1996) (0)
Matched-Pair A nalysis o f C onformal H igh-Dose-Rate Brachytherapy B oost V ersus E xternal-Beam R adiation Therapy A lone f or L ocally A dvanced P rostate C ancer (2000) (0)
Erratum to: Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema (2017) (0)
Use of Chemotherapy in Patients Receiving Hypofractionated Whole-Breast Irradiation: An Analysis within a State-Wide Quality Consortium (2019) (0)
Who Is a Candidate for APBI (2009) (0)
[Ambulatory use of G.34586 as a new antidepressive agent in therapy of endogenous forms with prevalence of anxiety]. (1971) (0)
Abstract P1-04-06: Characterization of recurrence risk after lumpectomy and radiotherapy in HER2-positive ductal carcinoma in situ of the breast, using 7-gene predictive biosignature: Implications for the NSABP-B43 trial results (2023) (0)
Reduced toxicity with conformal image-guided brachytherapy (C-IGBT) vs. adaptive image-guided radiotherapy (A-IGRT) for favorable risk prostate cancer (2007) (0)
Breast brachytherapy: Building a bright future on the foundation of a rich history of advancement in technology, technique, and patient-centered care. (2023) (0)
Dose Escalated Hypofractionated Radiotherapy Improves Metastasis Free and Survival for High-intermediate and High-risk Prostate Cancer Patients (2009) (0)
Long-term results for women with mammographically detected ductal carcinoma in-situ of the breast treated with breast-conserving surgery and definitive breast irradiation (2003) (0)
Breast / Soft Tissue The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation (0)
The effect of treatment variation on multi-leaf collimator dosimetry in conventional radiotherapy (1993) (0)
FIVE-YEAR TREATMENT EFFICACY AND COSMESIS BY THE AMERICAN SOCIETY OF BREAST SURGEONS MAMMOSITE® BREAST BRACHYTHERAPY REGISTRY TRIAL IN PATIENTS TREATED WITH ACCELERATED PARTIAL BREAST IRRADIATION (APBI) (2009) (0)
Response to Letter to the Editor Regarding “A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis” (2019) (0)
Limitations of the American Society of Therapeutic Radiology and Oncology (ASTRO) Consensus Panel Gu (2010) (0)
Intraoperative Radiation Therapy and Electronic Brachytherapy The American Brachytherapy Society consensus statement on intraoperative radiation therapy (0)
Abstract ES4-3: Techniques and technical considerations (2019) (0)
Is the Lumpectomy Cavity the Gold Standard for Image Guidance in Accelerated Partial Breast Irradiation (2008) (0)
274 THE IMPACT OF A PROSTATE MULTIDISCIPLINARY CLINIC PROGRAM ON PATIENT TREATMENT DECISIONS & ON ADHERENCE TO NCCN GUIDELINES (2012) (0)
Re: Examining the cost-effectiveness of radiation therapy among older women with favorable-risk breast cancer. (2014) (0)
Cost-Effectiveness Analysis of Ultra-Hypofractionated Whole Breast Radiation Therapy Alone vs. Endocrine Therapy Alone or Combined Treatment for Low-Risk ER-positive Early-Stage Breast Cancer in Women Age 65 and Older. (2022) (0)
Short Course, Two Day Accelerated Hypofractionated Partial Breast Balloon Brachytherapy: A Phase II Multi-Institutional Trial (2018) (0)
Local Control and Predictors of Local Recurrence Following MammoSite Radiation Therapy: 5-Year Outcomes (2011) (0)
The use of dose volume constraints to achieve rectal isotoxicity: A phase II prostate cancer radiation therapy dose escalation study (2004) (0)
Outcomes by breast cancer subtype in patients treated with accelerated partial breast irradiation. (2011) (0)
Ductal Carcinoma In Situ: Review of the Role of Radiation Therapy and Current Controversies (2015) (0)
In Regard to Vaidya et al. (2023) (0)
Dose Escalated Hypofractionated Radiotherapy Improves Cancer Related Events for High-Intermediate and High-Risk Prostate Cancer Patients at 10 Years (2010) (0)
Predictors of Receipt of Regional Nodal Irradiation in Patients With Pathologic Complete Response in the Axilla to Neoadjuvant Chemotherapy (2016) (0)
Higher rate of prostate-specific antigen bounce ≥2 ng/mL with brachytherapy in young prostate cancer patients (2009) (0)
Match Pair Analysis of Early Stage Breast Cancer Treated With Accelerated Partial Breast Irradiation or Whole Breast Radiation Therapy With 12 Year Follow-Up (2007) (0)
Chapter 62 – Noninvasive Breast Cancer (2016) (0)
Abstract C61: Reducing cancer incidence and mortality in African American, Arab American, and Chaldean communities in the Detroit metropolitan area utilizing a community‐based participatory process (2009) (0)
ASO Author Reflections: The Diminishing Impact of Margin Definitions and Width on Local Recurrence Rates following Breast-Conserving Therapy for Early-Stage Invasive Cancer: A Meta-analysis (2020) (0)
In Reply to Dr. Beal et al (2010) (0)
618 poster FOUR-YEAR RESULTS USING BALLOON BASED BRACHYTHER-APY TO DELIVER APBI WITH A TWO-DAY DOSE FRACTIONATION SCHEDULE (2011) (0)
Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Interstitial Brachytherapy Is Safe: First Results From the Tri-fraction Radiation Therapy Used to Minimize Patient Hospital Trips (TRIUMPH-T) Trial. (2023) (0)
Clinical efficacy of 2-day versus 5-day accelerated partial breast irradiation delivered via balloon-based brachytherapy: Results of a matched pair analysis. (2012) (0)
Breast brachytherapy. (2016) (0)
98 The use of high dose rate brachytherapy alone after lumpectomy in patients with early stage breast cancer treated with breast conserving therapy (2000) (0)
In response to Dr. Formenti et al. (2006) (0)
Impact of the number of cautionary/unsuitable risk factors on outcomes following accelerated partial breast irradiation. (2012) (0)
Abstracts of ASTRO proferred papers, posters, and scientific exhibit to be presentedOutcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma in-situ of the breast treated with conservative surgery and radiation therapy (1993) (0)
Effect of Lumpectomy Cavity Volume Change on the CTV for Accelerated Partial Breast Irradiation: A Deformable Registration Study (2008) (0)
External beam partial-breast radiotherapy : Crucial differences between NYL 00-23 and RTOG 0319: In regard to vicini. Authors' reply (2006) (0)
Brachytherapy-Based Accelerated Partial Breast Irradiation Versus Canadian Whole Breast Hypofractionation: A Matched-Pair Analysis of Comparative Effectiveness (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Fr. Andrea Vicini?

Fr. Andrea Vicini is affiliated with the following schools:

University of Michigan
Vanderbilt University
Virginia Commonwealth University